Pharmaceuticals
Excessive pricing practices in the pharmaceutical sector – NCAs’ scrutiny continues
02 August 2019 - Posted by: Nele De Backer
Last week, the Belgian and Italian consumer associations Test Aankoop/Test Achats and Altroconsumo filed complaints with their respective national competition authorities, alleging that the pharmaceutical group Biogen is abusing its dominant position by charging excessively high prices for the medicine Spinraza, which it has the exclusive right to market as an orphan drug until 2029. › Read More
Report on Competition Policy 2018: The pharmaceutical sector remains a priority
29 July 2019 - Posted by: Francesca Miotto
Last week, the European Commission (EC) published its Report on Competition Policy 2018, which provides a non-exhaustive summary of the activities undertaken by the EC in the field of competition law and policy in the year 2018.Whilst this report does not specifically refer to the pharmaceutical sector, the accompanying Commission Staff Working Document, which was › Read More
11 July 2019 - Posted by: Eveline Van Keymeulen
Today is a big day for legal cannabis in France. Earlier this morning, the French National Agency for Medicines and Health Products Safety (ANSM) endorsed the medical cannabis pilot programme per the recommendations of the French specialised committee on cannabis (CSST) which were published on 28 June (see our earlier blog post: “French cannabis committee › Read More
Belgium: New developments point at possibly imminent changes in (online) pharmacy market
02 July 2019 - Posted by: Tine Carmeliet
In Belgium, two recent events have drawn attention to the (online) pharmacy market. First, on 28 May 2019, the Competition Court of the Belgian Competition Authority (BCA) imposed a fine of EUR 1 million on the Belgian Order of Pharmacists for the use of anti-competitive practices aimed at excluding the MediCare-Market group, an association of (para)-pharmacies › Read More
French cannabis committee unveils recommendations for medical cannabis pilot programme in France
27 June 2019 - Posted by: Eveline Van Keymeulen
Yesterday, the French specialised committee on cannabis (CSST), which was established in mid-2018, held its last meeting and presented its final recommendations for the implementation of a medical cannabis pilot programme to the French National Agency for Medicines and Health Products Safety (ANSM). Last week, on 19 June 2019, the CSST had already published the › Read More